Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.64 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.50 |
| ▸ | ABAT | P80404 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.48 |
| ▸ | ALDH1A3 | P47895 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.44 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.41 |
| ▸ | DRD1 | P21728 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.39 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | STS | P08842 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3697863 | 0.90 | ALDH1A1 (0.59) | TYRCYP2A6HSD17B10ALDH5A1ABAT | |
| SCHEMBL9883870 | 0.90 | ALDH1A1 (0.59) | TYRCYP2A6HSD17B10ALDH5A1ABAT | |
| SCHEMBL2759071 | 0.88 | HSD17B10 (0.73) | TYRCYP2A6HSD17B10ALDH5A1ABAT | |
| SCHEMBL14340735 | 0.88 | CYP2A6 (0.73) | TYRCYP2A6HSD17B10ALDH5A1ABAT | |
| SCHEMBL15043306 | 0.82 | TYR (0.47) | TYRCYP2A6HSD17B10ALDH5A1ABAT | |
| SCHEMBL13701347 | 0.82 | ALDH1A1 (0.76) | TYRCYP2A6ALDH1A1ALDH1A3KDM4E | |
| SCHEMBL3696419 | 0.82 | TYR (0.69) | TYRCYP2A6HSD17B10ALDH5A1ABAT | |
| SCHEMBL3693965 | 0.82 | CYP2A6 (0.52) | TYRCYP2A6HSD17B10ALDH5A1ABAT | |
| SCHEMBL18286653 | 0.81 | TYR (0.50) | TYRCYP2A6HSD17B10ALDH5A1ABAT | |
| SCHEMBL31171 | 0.80 | CYP2A6 (0.69) | TYRCYP2A6HSD17B10ALDH5A1ABAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9328236-B2 | Polysiloxane modified resol resin, moulded bodies and composites obtained therefrom and methods for producing the resin, the moulded bodies and the composites | FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2016-05-03 | — | — | US | claimed |
| US-20140275373-A1 | POLYSILOXANE MODIFIED RESOL RESIN, MOULDED BODIES AND COMPOSITES OBTAINED THEREFROM AND METHODS FOR PRODUCING THE RESIN, THE MOULDED BODIES AND THE COMPOSITES | FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2014-09-18 | — | — | US | claimed |
| EP-2731992-A1 | POLYSILOXANE MODIFIED RESOL RESIN, MOULDED BODIES AND COMPOSITES OBTAINED THEREFROM AND METHODS FOR PRODUCING THE RESIN, THE MOULDED BODIES AND THE COMPOSITES | Fraunhofer Gesellschaft zur Förderung der angewandten Forschung E.V. (DE) | 2014-05-21 | — | — | EP | claimed |
| WO-2013007600-A1 | POLYSILOXANE MODIFIED RESOL RESIN, MOULDED BODIES AND COMPOSITES OBTAINED THEREFROM AND METHODS FOR PRODUCING THE RESIN, THE MOULDED BODIES AND THE COMPOSITES | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2013-01-17 | — | — | WO | claimed |
| EP-2731992-B1 | POLYSILOXANE MODIFIED RESOL RESIN, MOULDED BODIES AND COMPOSITES OBTAINED THEREFROM AND METHODS FOR PRODUCING THE RESIN, THE MOULDED BODIES AND THE COMPOSITES | FRAUNHOFER GES FORSCHUNG (DE) | 2017-04-12 | — | — | EP | disclosed |
| US-9328236-B2 | Polysiloxane modified resol resin, moulded bodies and composites obtained therefrom and methods for producing the resin, the moulded bodies and the composites | FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2016-05-03 | — | — | US | disclosed |
| US-20140275373-A1 | POLYSILOXANE MODIFIED RESOL RESIN, MOULDED BODIES AND COMPOSITES OBTAINED THEREFROM AND METHODS FOR PRODUCING THE RESIN, THE MOULDED BODIES AND THE COMPOSITES | FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2014-09-18 | — | — | US | disclosed |
| EP-2731992-A1 | POLYSILOXANE MODIFIED RESOL RESIN, MOULDED BODIES AND COMPOSITES OBTAINED THEREFROM AND METHODS FOR PRODUCING THE RESIN, THE MOULDED BODIES AND THE COMPOSITES | Fraunhofer Gesellschaft zur Förderung der angewandten Forschung E.V. (DE) | 2014-05-21 | — | — | EP | disclosed |
| WO-2013007600-A1 | POLYSILOXANE MODIFIED RESOL RESIN, MOULDED BODIES AND COMPOSITES OBTAINED THEREFROM AND METHODS FOR PRODUCING THE RESIN, THE MOULDED BODIES AND THE COMPOSITES | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2013-01-17 | — | — | WO | disclosed |
| US-20130018140-A1 | N-BRIDGED POLYNITRONS AND THE USE THEREOF AS CROSS-LINKING AGENTS, IN PARTICULAR IN COATING MATERIALS AND ADHESIVES | DICKMEIS MARCUS (DE) | 2013-01-17 | — | — | US | disclosed |
| EP-2516531-A1 | N-BRIDGED POLYNITRONS AND THE USE THEREOF AS CROSS-LINKERS, IN PARTICULAR IN COATING MATERIALS AND ADHESIVES | Dickmeis, Marcus (DE) | 2012-10-31 | — | — | EP | disclosed |
| EP-2516532-A2 | POLYOXAZIRIDINES AND USE THEREOF AS A CROSS-LINKING AGENT, ESPECIALLY IN COATING MATERIALS AND ADHESIVES | Dickmeis, Marcus (DE) | 2012-10-31 | — | — | EP | disclosed |
| WO-2011085793-A2 | POLYOXAZIRIDINES AND USE THEREOF AS A CROSS-LINKING AGENT, ESPECIALLY IN COATING MATERIALS AND ADHESIVES | DICKMEIS MARCUS (DE) | 2011-07-21 | — | — | WO | disclosed |
| WO-2011076392-A1 | N-BRIDGED POLYNITRONS AND THE USE THEREOF AS CROSS-LINKERS, IN PARTICULAR IN COATING MATERIALS AND ADHESIVES | DICKMEIS MARCUS (DE) | 2011-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130018140-A1 | N-BRIDGED POLYNITRONS AND THE USE THEREOF AS CROSS-LINKING AGENTS, IN PARTICULAR IN COATING MATERIALS AND ADHESIVES | PNN, PARN, NCLN | TYR 404/4885CYP2A6 3175/4885HSD17B10 4400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.